FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014106716> ?p ?o ?g. }

• W2014106716 endingPage "1667" @default.
• W2014106716 startingPage "1659" @default.
• W2014106716 abstract "A link between the use of alendronate and atypical diaphyseal femoral fracture has been suggested.The goal of this study was to evaluate the benefits of alendronate in preventing rehospitalization due to hip fractures and whether its use increases risk of hospitalization for atypical diaphyseal femoral fractures in Taiwan.Using Taiwan's National Health Insurance database, we identified women with osteoporosis with a first-ever hospitalization for vertebral or hip fractures between 2001 and 2007, which consisted of all patients receiving alendronate, raloxifene, calcitonin salmon, or teriparatide after the index fracture hospitalization. Data of untreated women were obtained as the untreated cohort. Study outcomes were defined as a rehospitalization due to hip fracture or a new hospitalization for subtrochanteric or diaphyseal femoral fracture.Among 11,278 women identified (mean age, 77 years), 2425 (21.5%) received alendronate, 2694 (23.9%) received other antiosteoporosis drugs, and 6159 (54.6%) were untreated. Patients in each group were comparable in fracture history and major comorbidities; untreated patients were more likely to have stroke (11.2%; P = 0.01) and those treated with alendronate were more likely to have a history of hyperlipidemia (16.2%; P = 0.03). Compared with the untreated patient cohort, our analysis suggested that patients prescribed alendronate were associated with decreased risk of rehospitalization due to hip fracture (hazard ratio = 0.67 [95% CI, 0.54-0.82]). Neither patients prescribed alendronate, nor those prescribed other antiosteoporosis drugs, differed significantly from the untreated patient cohort in terms of risk of hospitalization for atypical femoral fracture (adjusted hazard ratios = 0.77 and 0.49 [95% CI, 0.40-1.47 and 0.22-1.12], respectively). Consistent with these data, short- or long-term alendronate use was not found to be significantly associated with higher risk of atypical femoral fractures.This study in Taiwanese patients suggests that alendronate use was associated with a reduction in risk of rehospitalization due to hip fracture. We did not find a significant association between alendronate use and risk of hospitalization for atypical femoral fracture." @default.
• W2014106716 created "2016-06-24" @default.
• W2014106716 creator A5007848141 @default.
• W2014106716 creator A5022922423 @default.
• W2014106716 creator A5036677646 @default.
• W2014106716 creator A5038285208 @default.
• W2014106716 creator A5063414665 @default.
• W2014106716 creator A5086359211 @default.
• W2014106716 creator A5089326217 @default.
• W2014106716 date "2011-11-01" @default.
• W2014106716 modified "2023-10-05" @default.
• W2014106716 title "Hip and Subtrochanteric or Diaphyseal Femoral Fractures in Alendronate Users: A 10-Year, Nationwide Retrospective Cohort Study in Taiwanese Women" @default.
• W2014106716 cites W1975810697 @default.
• W2014106716 cites W1990771263 @default.
• W2014106716 cites W2000204187 @default.
• W2014106716 cites W2005298224 @default.
• W2014106716 cites W2010029465 @default.
• W2014106716 cites W2013089207 @default.
• W2014106716 cites W2015755164 @default.
• W2014106716 cites W2019104204 @default.
• W2014106716 cites W2021327935 @default.
• W2014106716 cites W2022094899 @default.
• W2014106716 cites W2053192539 @default.
• W2014106716 cites W2053775515 @default.
• W2014106716 cites W2057332307 @default.
• W2014106716 cites W2073850949 @default.
• W2014106716 cites W2073927307 @default.
• W2014106716 cites W2105086949 @default.
• W2014106716 cites W2111387898 @default.
• W2014106716 cites W2151825217 @default.
• W2014106716 cites W2153009489 @default.
• W2014106716 doi "https://doi.org/10.1016/j.clinthera.2011.09.006" @default.
• W2014106716 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22018450" @default.
• W2014106716 hasPublicationYear "2011" @default.
• W2014106716 type Work @default.
• W2014106716 sameAs 2014106716 @default.
• W2014106716 citedByCount "36" @default.
• W2014106716 countsByYear W20141067162012 @default.
• W2014106716 countsByYear W20141067162013 @default.
• W2014106716 countsByYear W20141067162014 @default.
• W2014106716 countsByYear W20141067162015 @default.
• W2014106716 countsByYear W20141067162016 @default.
• W2014106716 countsByYear W20141067162017 @default.
• W2014106716 countsByYear W20141067162018 @default.
• W2014106716 countsByYear W20141067162020 @default.
• W2014106716 countsByYear W20141067162021 @default.
• W2014106716 countsByYear W20141067162022 @default.
• W2014106716 countsByYear W20141067162023 @default.
• W2014106716 crossrefType "journal-article" @default.
• W2014106716 hasAuthorship W2014106716A5007848141 @default.
• W2014106716 hasAuthorship W2014106716A5022922423 @default.
• W2014106716 hasAuthorship W2014106716A5036677646 @default.
• W2014106716 hasAuthorship W2014106716A5038285208 @default.
• W2014106716 hasAuthorship W2014106716A5063414665 @default.
• W2014106716 hasAuthorship W2014106716A5086359211 @default.
• W2014106716 hasAuthorship W2014106716A5089326217 @default.
• W2014106716 hasConcept C126322002 @default.
• W2014106716 hasConcept C141071460 @default.
• W2014106716 hasConcept C167135981 @default.
• W2014106716 hasConcept C201903717 @default.
• W2014106716 hasConcept C207103383 @default.
• W2014106716 hasConcept C2775854910 @default.
• W2014106716 hasConcept C2776541429 @default.
• W2014106716 hasConcept C2776886416 @default.
• W2014106716 hasConcept C2777251235 @default.
• W2014106716 hasConcept C2777308945 @default.
• W2014106716 hasConcept C2778885795 @default.
• W2014106716 hasConcept C2779809032 @default.
• W2014106716 hasConcept C44249647 @default.
• W2014106716 hasConcept C71924100 @default.
• W2014106716 hasConcept C72563966 @default.
• W2014106716 hasConceptScore W2014106716C126322002 @default.
• W2014106716 hasConceptScore W2014106716C141071460 @default.
• W2014106716 hasConceptScore W2014106716C167135981 @default.
• W2014106716 hasConceptScore W2014106716C201903717 @default.
• W2014106716 hasConceptScore W2014106716C207103383 @default.
• W2014106716 hasConceptScore W2014106716C2775854910 @default.
• W2014106716 hasConceptScore W2014106716C2776541429 @default.
• W2014106716 hasConceptScore W2014106716C2776886416 @default.
• W2014106716 hasConceptScore W2014106716C2777251235 @default.
• W2014106716 hasConceptScore W2014106716C2777308945 @default.
• W2014106716 hasConceptScore W2014106716C2778885795 @default.
• W2014106716 hasConceptScore W2014106716C2779809032 @default.
• W2014106716 hasConceptScore W2014106716C44249647 @default.
• W2014106716 hasConceptScore W2014106716C71924100 @default.
• W2014106716 hasConceptScore W2014106716C72563966 @default.
• W2014106716 hasFunder F4320332813 @default.
• W2014106716 hasIssue "11" @default.
• W2014106716 hasLocation W20141067161 @default.
• W2014106716 hasLocation W20141067162 @default.
• W2014106716 hasOpenAccess W2014106716 @default.
• W2014106716 hasPrimaryLocation W20141067161 @default.
• W2014106716 hasRelatedWork W1943094800 @default.
• W2014106716 hasRelatedWork W2042156239 @default.
• W2014106716 hasRelatedWork W2093546889 @default.
• W2014106716 hasRelatedWork W2136235470 @default.
• W2014106716 hasRelatedWork W2162326107 @default.
• W2014106716 hasRelatedWork W2728709142 @default.

• next